^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CYAD-01
i
Other names: CYAD-01, CAR-T NKG2D, NKR-2, NKR-2 T-cell, CAR-T NKR-2, CM-CS-1, CAR NKG2D, NKR-2 T-cell immunotherapy, CM-CS1 infusion, chimeric antigen receptor modified T-cells targeting NKG2D-ligands
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Celdara Medical, Celyad Oncology
Drug class:
T lymphocyte replacement, NKG2D-targeted CAR-T immunotherapy
Related drugs:
